📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China. (2016)

First Author: Berry C

Attributed to: Tuberculosis Treatment Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1183/13993003.01646-2015

PubMed Identifier: 27132271

Publication URI: http://europepmc.org/abstract/MED/27132271

Type: Journal Article/Review

Volume: 47

Parent Publication: The European respiratory journal

Issue: 5

ISSN: 0903-1936